Adaptive Phage Therapeutics

  • About APT
  • COVID-19 Vaccine
  • Contact
  • Careers
  • The Science
  • Pipeline
  • Case Studies
  • News Room
  • Patient Access
  • Style Guide

News Room

Latest Press Releases

  • Adaptive Phage Therapeutics to Participate in the NobleCon17 Virtual Investor ConferenceJanuary 15, 2021
  • FDA Clears Expanded Access IND for APT’s PhageBank™ Therapy to Combat COVID-19-related Bacterial InfectionsNovember 18, 2020
  • PhageBank™ Deployed in Texas Outbreak of Life-Threatening Carbapenem Resistant A. baumannii (CRAB) in COVID-19 PatientsNovember 2, 2020
  • Adaptive Phage Therapeutics Receives Orphan Drug Designation for PhageBank™ in Prosthetic Joint InfectionsOctober 22, 2020
  • Adaptive Phage Therapeutics Receives Department of Defense Award for Development of COVID-19 VaccineAugust 20, 2020
  • Adaptive Phage Therapeutics Announces Mayo Clinic as Lead Investor in Convertible Note FinancingAugust 5, 2020
  • Adaptive Phage Therapeutics Enters Agreement with Mayo Clinic to Commercialize a Phage Susceptibility TestJune 9, 2020
  • FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant InfectionsMarch 12, 2020
  • Adaptive Phage Therapeutics Selected for Startup Grind’s Global 2020 Accelerate ProgramFebruary 10, 2020

See all press releases

Get to know us

Featured Stories

Company Fact sheet

Adaptive Phage Therapeutics

  • About APT
  • COVID-19 Vaccine
  • Contact
  • Careers
  • The Science
  • Pipeline
  • Case Studies
  • News Room
  • Patient Access
  • Style Guide
  • LinkedIn
  • Twitter
  • Email
  • Directory